133 related articles for article (PubMed ID: 29962402)
21. Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.
Cabanes A; Tzemach D; Goren D; Horowitz AT; Gabizon A
Clin Cancer Res; 1998 Feb; 4(2):499-505. PubMed ID: 9516942
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs.
Qiao L; Hu S; Huang K; Su T; Li Z; Vandergriff A; Cores J; Dinh PU; Allen T; Shen D; Liang H; Li Y; Cheng K
Theranostics; 2020; 10(8):3474-3487. PubMed ID: 32206102
[TBL] [Abstract][Full Text] [Related]
23. A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research.
Emam SE; Ando H; Abu Lila AS; Shimizu T; Ukawa M; Okuhira K; Ishima Y; Mahdy MA; Ghazy FS; Ishida T
Biol Pharm Bull; 2018; 41(5):733-742. PubMed ID: 29709910
[TBL] [Abstract][Full Text] [Related]
24. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
[TBL] [Abstract][Full Text] [Related]
25. Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging.
Seynhaeve ALB; Dicheva BM; Hoving S; Koning GA; Ten Hagen TLM
J Control Release; 2013 Nov; 172(1):330-340. PubMed ID: 24012486
[TBL] [Abstract][Full Text] [Related]
26. Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells.
Harmati M; Tarnai Z; Decsi G; Kormondi S; Szegletes Z; Janovak L; Dekany I; Saydam O; Gyukity-Sebestyen E; Dobra G; Nagy I; Nagy K; Buzas K
J Oral Pathol Med; 2017 Apr; 46(4):259-266. PubMed ID: 27598726
[TBL] [Abstract][Full Text] [Related]
27. Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone.
Koch R; Aung T; Vogel D; Chapuy B; Wenzel D; Becker S; Sinzig U; Venkataramani V; von Mach T; Jacob R; Truemper L; Wulf GG
Clin Cancer Res; 2016 Jan; 22(2):395-404. PubMed ID: 26369630
[TBL] [Abstract][Full Text] [Related]
28. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.
Yahuafai J; Asai T; Oku N; Siripong P
Biol Pharm Bull; 2018; 41(7):1103-1106. PubMed ID: 29962406
[TBL] [Abstract][Full Text] [Related]
29. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
[TBL] [Abstract][Full Text] [Related]
30. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
[TBL] [Abstract][Full Text] [Related]
31. Equivalency challenge: Evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model.
Smith JA; Mathew L; Burney M; Nyshadham P; Coleman RL
Gynecol Oncol; 2016 May; 141(2):357-363. PubMed ID: 26946092
[TBL] [Abstract][Full Text] [Related]
32. Intracellular PK/PD Relationships of Free and Liposomal Doxorubicin: Quantitative Analyses and PK/PD Modeling.
Soininen SK; Vellonen KS; Heikkinen AT; Auriola S; Ranta VP; Urtti A; Ruponen M
Mol Pharm; 2016 Apr; 13(4):1358-65. PubMed ID: 26950248
[TBL] [Abstract][Full Text] [Related]
33. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles.
Colombo M; Moita C; van Niel G; Kowal J; Vigneron J; Benaroch P; Manel N; Moita LF; Théry C; Raposo G
J Cell Sci; 2013 Dec; 126(Pt 24):5553-65. PubMed ID: 24105262
[TBL] [Abstract][Full Text] [Related]
34. Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats.
Yokoe J; Sakuragi S; Yamamoto K; Teragaki T; Ogawara K; Higaki K; Katayama N; Kai T; Sato M; Kimura T
Int J Pharm; 2008 Apr; 353(1-2):28-34. PubMed ID: 18082345
[TBL] [Abstract][Full Text] [Related]
35. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
Shiraga E; Barichello JM; Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
[TBL] [Abstract][Full Text] [Related]
36. Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.
Kong JN; He Q; Wang G; Dasgupta S; Dinkins MB; Zhu G; Kim A; Spassieva S; Bieberich E
Int J Cancer; 2015 Oct; 137(7):1610-20. PubMed ID: 25833198
[TBL] [Abstract][Full Text] [Related]
37. Multimodal transfer of MDR by exosomes in human osteosarcoma.
Torreggiani E; Roncuzzi L; Perut F; Zini N; Baldini N
Int J Oncol; 2016 Jul; 49(1):189-96. PubMed ID: 27176642
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.
Kibria G; Hatakeyama H; Sato Y; Harashima H
Int J Pharm; 2016 Jul; 509(1-2):178-187. PubMed ID: 27234700
[TBL] [Abstract][Full Text] [Related]
39. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
40. The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251.
Killion JJ; Beltran P; O'Brian CA; Yoon SS; Fan D; Wilson MR; Fidler IJ
Oncol Res; 1995; 7(9):453-9. PubMed ID: 8835289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]